The effects of alpha-lipoic acid on MMP-2 and MMP-9 activities in a rat renal ischemia and re-perfusion model

Abstract

Matrix metalloproteinases (MMPs) are enzymes that are responsible for degradation of extracellular matrix (ECM); they are involved in the pathogenesis of ischemia-re-perfusion (I-R) injury. We investigated the possible preventive effect of alpha-lipoic acid (LA) in a renal I-R injury model in rats by assessing its reducing effect on the expression and activation of MMP-2 and MMP-9 induced by I-R. Rats were assigned to four groups: control, sham-operated, I-R (saline, i.p.) and I-R+ LA (100 mg/kg, i.p.). After a right nephrectomy, I-R was induced by clamping the left renal pedicle for 1 h, followed by 6 h re-perfusion. In the sham group, a right nephrectomy was performed and left renal pedicles were dissected without clamping and the entire left kidney was excised after 6 h. LA pretreatment was started 30 min prior to induction of ischemia. Injury to tubules was evaluated using light and electron microscopy. The expressions of MMP-2 and MMP-9 were determined by immunohistochemistry and their activities were analyzed by gelatin zymography. Serum creatinine was measured using a quantitative kit based on the Jaffe colorimetric technique. Malondialdehyde (MDA) and glutathione (GSH) were analyzed using high performance liquid chromatography. Tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-1 were assessed using enzyme-linked immunosorbent assay (ELISA). I-R caused tubular dilatation and brush border loss. LA decreased both renal dysfunction and abnormal levels of MDA and GSH during I-R. Moreover, LA decreased significantly both MMP-2 and MMP-9 expressions and activations during I-R. TIMP-1 and TIMP-2 levels were increased significantly by LA administration. LA modulated increased MMP-2 and MMP-9 activities and decreased TIMP-1 and TIMP-2 levels during renal I-R.

α‐Lipoic acid prolongs survival and attenuates acute kidney injury in a rat model of sepsis

“…The beneficial actions of ALA observed in the present study are consistent with previous studies showing that ALA has potent protective effects against different acute or chronic kidney diseases . Thus, our observations not only add to a growing body of evidence demonstrating the effectiveness of ALA administration in treating sepsis‐associated multiple organ dysfunction, but also indicate that future in‐depth studies evaluating the potential of ALA therapy would be worthwhile.…”

Alpha-Lipoic Acid Preconditioning and Ischaemic Postconditioning Synergistically Protect Rats from Cerebral Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/ NF-κB Signaling Pathway

“…Due to its strong antioxidant effect, ALA has also been demonstrated to exert a similar protective effect in non-neuronal tissue as well. For instance, preconditioning or postconditioning with ALA is protective against I/RI-induced cardiac dysfunction, retinal damage, ovarian torsion injury and reperfusioninduced renal failure [25][26][27][28]. The latest clinical research has uncovered that the protective mechanisms of ALAP against simultaneous kidney-pancreas transplantation-induced renal dysfunction and post-transplant pancreatitis occur through its anti-inflammatory effects [29].…”

Pretreatment with nebivolol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischaemia–reperfusion injury

“…However, MMP‐2 is expressed in the glomerulus and proximal tubules of rats, MMP‐9 expression is mainly confined to glomeruli, although expression in the proximal and distal tubules of the monkey has been demonstrated . Recent data suggests the role of MMPs in pathophysiology of IRI, one of the major causes of acute kidney injury (AKI) in certain clinical situations . The pathophysiology may involve a complex interaction between vascular endothelium, inflammation, and tubular injury.…”